Mouse model for sepsis
脓毒症小鼠模型
基本信息
- 批准号:7579942
- 负责人:
- 金额:$ 38.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffinityAgonistAlveolar MacrophagesAmmonium SulfateAnimal ModelAnimalsBacteriaBacterial ToxinsBiologicalBiological AssayBloodBone MarrowCattleCaviaCell Adhesion MoleculesCell LineCellsChargeChickensCommunicable DiseasesComplexCultured CellsDNADataEndothelial CellsEnzyme-Linked Immunosorbent AssayEquus caballusFamily suidaeFlagellinFutureGoalsGram-Positive BacteriaHamstersHandHeatingHigh Pressure Liquid ChromatographyHumanHydrophobicityIRAK3 geneImmune responseIn VitroInterleukin-6LeadLectinLipopolysaccharidesLipoproteinsLiteratureLizardsLungMAPK14 geneMass Spectrum AnalysisMediatingMolecularMusOryctolagus cuniculusPan GenusPapioPatternPeptidoglycanPeripheral Blood Mononuclear CellPeritonealPeritoneal MacrophagesPhosphotransferasesPopulationProductionProteinsRattusResearch PersonnelResistanceRodentSTAT3 geneSamplingSepsisSerumSignal TransductionSourceStimulusSystemTLR2 geneTNF geneTechniquesTechnologyTestingTimeTissuesToll-like receptorsToxinUmbilical veinWorkbasecell typecytokinedesignfetalhuman IRAK1 proteininterestkillingsmacrophagemicrobialmonocytemouse modelpathogenperipheral bloodprogramsprotein purificationresearch studyresistance mechanismresponsetwo-dimensional
项目摘要
DESCRIPTION (provided by applicant):
Mice are one of the most commonly utilized species for the initial study of many infectious diseases, including the study of the host response to bacteria. However, mice are 100 to 100,000- fold more resistant than humans in most biological responses to the effects of bacterial lipopolysaccharide (LPS), and to many other microbial toxins. In the literature, and in our hands, macrophages from the two species are generally similar in their sensitivity to LPS, regardless of source. Our preliminary data indicate that there is a soluble substance in the serum of mice that strongly suppresses the production of IL-6 and TNF from mouse and human macrophages that are stimulated with many pathogen associated molecular pattern molecules (PAMPs). These data raise the possibility that the reason that mice are resistant to LPS and other bacterial toxins is the presence of this factor in their blood. The overall goal of the proposed work is to understand the mechanism(s) by which mice are resistant to LPS. Our first specific aim is to systematically study the sensitivity of macrophages and endothelial cells from different tissue compartments from mice and humans (where possible), as well as in cell lines, in the presence of serum from LPS-resistant animals (eg rodent, baboon) and LPS-sensitive animals (eg human, fetal calf). Our second specific aim is to purify the material from mouse serum that inhibits the production of TNF from mouse macrophages. Our third specific aim is to study the cellular level of signaling that is inhibited. The project has broad significance because most experiments using mouse cells are currently performed using media supplemented with fetal calf serum rather than mouse serum, because the proposed work will further our understanding of sepsis caused by bacterial pathogens, and because the work could eventually lead to better animal models for the study of sepsis.
描述(由申请人提供):
在许多传染病的初始研究中,小鼠是最常用的物种之一,包括研究宿主对细菌的反应。然而,在大多数生物反应中,小鼠对细菌脂多糖(LPS)的影响和许多其他微生物毒素的抵抗力是人类的100到100,000倍。在文献中和我们手中,这两个物种的巨噬细胞对内毒素的敏感性通常相似,无论来源如何。我们的初步数据表明,小鼠血清中存在一种可溶性物质,它能强烈抑制许多病原体相关分子模式分子(PAMPs)刺激的小鼠和人巨噬细胞产生IL-6和TNF。这些数据提出了一种可能性,即小鼠对内毒素和其他细菌毒素具有抵抗力的原因是它们的血液中存在这种因素。这项拟议工作的总体目标是了解小鼠抵抗内毒素的机制(S)。我们的第一个特定目标是系统地研究来自小鼠和人类不同组织隔室的巨噬细胞和内皮细胞(如果可能)以及在细胞系中,存在内毒素抵抗的动物(例如啮齿动物、狒狒)和内毒素敏感的动物(例如人、胎牛)的血清的敏感性。我们的第二个特定目标是从小鼠血清中提纯抑制小鼠巨噬细胞产生肿瘤坏死因子的物质。我们的第三个具体目标是研究被抑制的信号的细胞水平。该项目具有广泛的意义,因为目前使用小鼠细胞进行的大多数实验都是使用添加胎牛血清而不是小鼠血清的培养液进行的,因为拟议的工作将加深我们对细菌病原体引起的脓毒症的理解,并且因为该工作最终可能导致更好的脓毒症动物模型的研究。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hemopexin in severe inflammation and infection: mouse models and human diseases.
- DOI:10.1186/s13054-015-0885-x
- 发表时间:2015-04-15
- 期刊:
- 影响因子:0
- 作者:Lin T;Maita D;Thundivalappil SR;Riley FE;Hambsch J;Van Marter LJ;Christou HA;Berra L;Fagan S;Christiani DC;Warren HS
- 通讯作者:Warren HS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H Shaw Warren其他文献
H Shaw Warren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H Shaw Warren', 18)}}的其他基金
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
8365462 - 财政年份:2011
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
8170699 - 财政年份:2010
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
7957005 - 财政年份:2009
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
7721392 - 财政年份:2008
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
7602869 - 财政年份:2007
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
7359109 - 财政年份:2006
- 资助金额:
$ 38.14万 - 项目类别:
PROTEOMIC CHARACTERIZATION OF CEREBROSPINAL FLUID BY HIGH RESOLUTION LC-MS/MS
通过高分辨率 LC-MS/MS 进行脑脊液蛋白质组学表征
- 批准号:
7183184 - 财政年份:2005
- 资助金额:
$ 38.14万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




